An Expert’s Guide To Switching In Germany, Part 2: Improving The Reclassification Process

In Part 2 of this exclusive interview, Elmar Kroth, scientific director of the German Medicines Manufacturers´ Association, the BAH, tells HBW Insight what the association is doing to improve the prescription-to-OTC switch process in Germany. 

ElmarKroth
The BAH's scientific director Elmar Kroth • Source: BAH

More from Rx-to-OTC Switch

More from Health